A systems biology approach to identify molecular pathways altered by HDAC inhibition in osteosarcoma

The histone deacetylase inhibitor valproic acid sensitizes human and canine osteosarcoma to doxorubicin

(2010) Luke A. Wittenburg et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

A work in progress: The clinical development of histone deacetylase inhibitor

(2010) Silvia Marsoni et al.   Epigenetics

Wnt Inhibitory Factor 1 Decreases Tumorigenesis and Metastasis in Osteosarcoma

(2010) E. M. Rubin et al.   MOLECULAR CANCER THERAPEUTICS

Erratum: Profiling of high-grade central osteosarcoma and its putative progenitor cells identifies tumourigenic pathways

(2009) A-M Cleton-Jansen et al.   BRITISH JOURNAL OF CANCER

Genome-wide Loss-of-Function Screen Reveals an Important Role for the Proteasome in HDAC Inhibitor-Induced Apoptosis

(2009) Susan Fotheringham et al.   CANCER CELL

Clinical Studies of Histone Deacetylase Inhibitors

(2009) H. M. Prince et al.   CLINICAL CANCER RESEARCH

Inactive Wnt/β-catenin pathway in conventional high-grade osteosarcoma

(2009) Yongping Cai et al.   JOURNAL OF PATHOLOGY

Expression of Hypoxia-Inducible Factor-1α, Histone Deacetylase 1, and Metastasis-Associated Protein 1 in Pancreatic Carcinoma

(2009) Kotaro Miyake et al.   PANCREAS

Systems biology approach to identification of biomarkers for metastatic progression in cancer

(2008) Andrey A Ptitsyn et al.   BMC BIOINFORMATICS

Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy

(2008) W Weichert et al.   BRITISH JOURNAL OF CANCER

Class I Histone Deacetylase Expression Has Independent Prognostic Impact in Human Colorectal Cancer: Specific Role of Class I Histone Deacetylases In vitro and In vivo

(2008) W. Weichert et al.   CLINICAL CANCER RESEARCH

Proteasome Inhibitors in Cancer Therapy: Lessons from the First Decade

(2008) R. Z. Orlowski et al.   CLINICAL CANCER RESEARCH

Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis

(2008) Wilko Weichert et al.   LANCET ONCOLOGY